ProPublica is an independent, non-profit news agency that produces investigative journalism in the public interest – and this year, it became the first online newsroom to win the Pulitzer Prize for investigative reporting. When they start digging, they find something interesting. Lately, ProPublica has been investigating Big Pharma marketing, particularly the growing practice of recruiting, training and paying doctors to give presentations to other docs about specific drugs.
They’re part of the pharmaceutical industry’s white-coat sales force, doctors paid to promote brand name prescription drugs to their peers — and if they’re convincing enough, to get more physicians to prescribe them. Continue reading →
A few years ago, Sheffield University in the U.K. offered over $250,000 to one of its senior medical professors if he would agree to stop criticizing the drug company that was giving research money to the university’s medical school.
For several years, bone metabolism specialist Dr. Aubrey Blumsohn had been complaining to his university about scientific misconduct around a contract between Sheffield and the U.S.-based drug company, Procter & Gamble Pharmaceuticals. Blumsohn claimed that the company had denied him access to his own key research data on the P&G drug Actonel, and then tried to ghostwrite his analysis of it for publication. Continue reading →